104 related articles for article (PubMed ID: 36293167)
1. The Effect of Retinoic Acid on Arsenite-Transformed Malignant UROtsa Bladder Cancer Cells: In Vitro Model of Basal Muscle-Invasive Bladder Cancer.
Al-Marsoummi S; Mehus AA; Garrett SH; Sens DA; Somji S
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539513
[TBL] [Abstract][Full Text] [Related]
2. Predicting the biological behavior of non-muscle-invasive bladder cancer: from histology to molecular taxonomy.
Luchini C; Cheng L
Transl Androl Urol; 2017 Oct; 6(5):987-990. PubMed ID: 29184801
[No Abstract] [Full Text] [Related]
3. Association between urinary phthalates and phthalate metabolites and cancer risk: A systematic review and meta-analysis.
Meng M; Yang Y; Song L; Peng J; Li S; Gao Z; Bu Y; Gao J
Heliyon; 2024 Apr; 10(8):e29684. PubMed ID: 38665549
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro.
Xie H; Rutz J; Maxeiner S; Grein T; Thomas A; Juengel E; Chun FK; Cinatl J; Haferkamp A; Tsaur I; Blaheta RA
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474751
[TBL] [Abstract][Full Text] [Related]
5. Chronic arsenic exposure induces malignant transformation of human HaCaT cells through both deterministic and stochastic changes in transcriptome expression.
Banerjee M; Srivastava S; Rai SN; States JC
Toxicol Appl Pharmacol; 2024 Mar; 484():116865. PubMed ID: 38373578
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles to analyze the anticancer and carcinogenic effects of arsenic in bladder cancer.
Han X; Zhang T; Ma Q; Chang R; Xin S; Yu Q; Zhang G; Wang Y
Am J Transl Res; 2023; 15(10):5984-5996. PubMed ID: 37969188
[TBL] [Abstract][Full Text] [Related]
7. M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.
Xie J; Zhang H; Wang K; Ni J; Ma X; Khoury CJ; Prifti V; Hoard B; Cerenzia EG; Yin L; Zhang H; Wang R; Zhuo D; Mao W; Peng B
Oncogene; 2023 Sep; 42(40):2956-2970. PubMed ID: 37612524
[TBL] [Abstract][Full Text] [Related]
8. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
[TBL] [Abstract][Full Text] [Related]
9. The urothelial gene regulatory network: understanding biology to improve bladder cancer management.
Ramal M; Corral S; Kalisz M; Lapi E; Real FX
Oncogene; 2024 Jan; 43(1):1-21. PubMed ID: 37996699
[TBL] [Abstract][Full Text] [Related]
10. Chronic Arsenic Exposure Upregulates the Expression of Basal Transcriptional Factors and Increases Invasiveness of the Non-Muscle Invasive Papillary Bladder Cancer Line RT4.
Mehus AA; Bergum N; Knutson P; Shrestha S; Kalonick M; Zhou X; Garrett SH; Sens DA; Sens MA; Somji S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293167
[TBL] [Abstract][Full Text] [Related]
11. The urothelial cell line UROtsa transformed by arsenite and cadmium display basal characteristics associated with muscle invasive urothelial cancers.
Hoggarth ZE; Osowski DB; Freeberg BA; Garrett SH; Sens DA; Sens MA; Zhou XD; Zhang KK; Somji S
PLoS One; 2018; 13(12):e0207877. PubMed ID: 30550540
[TBL] [Abstract][Full Text] [Related]
12. Activation of PPARγ and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells.
Mehus AA; Bergum N; Knutson P; Shrestha S; Zhou XD; Garrett SH; Sens DA; Sens MA; Somji S
PLoS One; 2020; 15(8):e0237976. PubMed ID: 32822399
[TBL] [Abstract][Full Text] [Related]
13. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
[TBL] [Abstract][Full Text] [Related]
14. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder.
Calvete J; Larrinaga G; Errarte P; Martín AM; Dotor A; Esquinas C; Nunes-Xavier CE; Pulido R; López JI; Angulo JC
Hum Pathol; 2019 Sep; 91():61-68. PubMed ID: 31279874
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
